Company · CIK 0001311596
Tobira Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ATobira Therapeutics, Inc.0000315066-17-002077 · 8.1 KBSEC(opens sec.gov)
- SC 13G/ATobira Therapeutics, Inc.0001104659-17-002759 · 158.9 KBSEC(opens sec.gov)
- SC 13D/ATobira Therapeutics, Inc.0000904454-16-001545 · 94.6 KBSEC(opens sec.gov)
- 4Insider trades0000904454-16-001535 · 21.2 KBSEC(opens sec.gov)
- 4Insider trades0000904454-16-001533 · 11.0 KBSEC(opens sec.gov)
- 4Insider trades0000904454-16-001531 · 12.2 KBSEC(opens sec.gov)
- 4Insider trades0000904454-16-001529 · 12.1 KBSEC(opens sec.gov)
- 4Insider trades0000904454-16-001527 · 11.0 KBSEC(opens sec.gov)
- 4Insider trades0001012975-16-001554 · 4.9 KBSEC(opens sec.gov)
- SC 13D/ATobira Therapeutics, Inc.0001193125-16-759083 · 40.4 KBSEC(opens sec.gov)
Insiders
- Allergan plc10% Owner
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- BLAIR JAMES C10% Owner
- Brosgart Carol LDirector
- BVF INC/ILSee Explanation of Responses
- BVF PARTNERS L P/ILSee Explanation of Responses
- Clark B. JeffersonDirector
- Cooper Jeffrey HDirector
- DOMAIN ASSOCIATES10% Owner
- DOMAIN PARTERS VII L P10% Owner
Tickers
No tickers on record.
Addresses
business
701 GATEWAY BLVD SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
701 GATEWAY BLVD SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
Former names
- Tibira Therapeutics, Inc.2015-05-06
- Regado Biosciences Inc2015-05-06
Same industry